![](/img/cover-not-exists.png)
Chronic treatment with irinotecan activates the PI3K/Akt/mTOR pathway in HT-29 colon cancer xenografts
K.K. Souza, J.C. Oliveira, M.M. Dias, E.R. Ropelle, G.Z. Rocha, F.O. Costa, J.B.C. CarvalheiraVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71298-9
File:
PDF, 89 KB
english, 2008